ReachBio provides specialized contract research services and primary cell biology research tools to the drug development and life science research communities worldwide.
News from ReachBio Research Labs:
ReachBio Research Labs Launches New Immunology Services
New assays reflect growth in company's customized primary human cell biology contract research business SEATTLE, March 18, 2015 /PRNewswire/ — ReachBio Research Labs (http://www.reachbio.com), a Seattle-based contract research company specializing in primary cell biology, announced today the roll-out of a platform of immunology-based assays and the hiring of an experienced scientific manager for its new immunology […]
Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan
Agreement also gives Funakoshi rights to promote ReachBio's contract cell biology research services. SEATTLE, Nov. 12, 2014 /PRNewswire/ — ReachBio Research Labs (a registered trade name of ReachBio LLC, Seattle, WA) announced today that it has signed an agreement with Funakoshi Co., Ltd. (Tokyo, Japan), giving Funakoshi non-exclusive distribution rights to ReachBio's human primary cell product […]
Extension of trade name reflects growth in customized primary cell biology contract research business SEATTLE, April 28, 2014 /PRNewswire/ — ReachBio LLC announced today that it is extending its trade name and will start doing business as ReachBio Research Labs, effective immediately. As part of this rebranding, the company has updated its logo and launched […]
